All News

Found 16,438 articles

• EraGen Biosciences Inc. Closes On $12 Million In Series A Financing

  1/9/2006

• Idenix Pharmaceuticals, Inc. Reports Positive 4-Week Data From A Phase IIb Clinical Trial Evaluating Valopicitabine (NM283) Combined With Pegylated Interferon In Treatment-Naive Hepatitis C Patients

  1/9/2006

• U.S. Federal District Court In Indianapolis Rules In Emisphere Technologies, Inc.'s Favor That Eli Lilly and Company Breached Its License Agreement With Emisphere Technologies, Inc. For Oral PTH

  1/9/2006

• Breakthrough Therapeutics Release: Vaccine For Chronic Myeloid Leukemia Active In Patients With Persistent Disease

  1/6/2006

• Amicus Therapeutics, Inc. Appoints David J. Lockhart Chief Scientific Officer

  1/6/2006

• Genentech, Inc. Announces Executive Promotions

  1/6/2006

• Myogen To Present At The JPMorgan Healthcare Conference

  1/6/2006

• Emisphere Technologies, Inc. Announces Pending Verdict In Litigation Against Eli Lilly and Company

  1/5/2006

• Anadys Pharmaceuticals, Inc. To Present At The 24th Annual JP Morgan Healthcare Conference

  1/5/2006

• Protein Design Labs, Inc. Grants Patent Licenses To Merck & Co., Inc. For Humanized Antibodies Against Two Undisclosed Antigens

  1/4/2006

• Tanox, Inc. To Present At JP Morgan Healthcare Conference

  1/4/2006

• Santhera Pharmaceuticals AG Announces Management Buy-Out Of The Graffinity Drug Discovery Technology Business

  1/3/2006

• East Bay Biotechs Hit Sales Block

  1/3/2006

• Idenix Pharmaceuticals, Inc. And Novartis Pharmaceuticals Corporation Announce New Drug Application Submitted To The U.S. Novartis Pharmaceuticals Corporation For Telbivudine For The Treatment Of Chronic Hepatitis B

  1/3/2006

• Sirtris Pharmaceuticals To Present At JP Morgan 24th Annual Healthcare Conference

  1/3/2006

• Genentech, Inc. Submits Biologics License Application For FDA Review Of Lucentis(TM) In Wet Age-Related Macular Degeneration

  12/30/2005

• Novartis Pharmaceuticals Corporation's Femara(R) Receives US Approval As Initial Therapy For Postmenopausal Women With Early Breast Cancer After Surgery

  12/29/2005

• Drug Firms Make More Study Results Public

  12/29/2005

• The Day In Review: Alkermes And Cephalon, Inc. Alcohol Drug Gets Approvable Letter

  12/29/2005

• Novartis Pharma K.K. Files Applicaion Seeking Additional Indication For Glivec In Japan

  12/27/2005